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Abstract
Background: Many people now take multiple medications on a long-term basis to manage health conditions.
Optimising the benefit of such polypharmacy requires tailoring of medicines use to the needs and circumstances of
individuals. However, professionals report barriers to achieving this in practice. In this study, we examined health
professionals’ perceptions of enablers and barriers to delivering individually tailored prescribing.
Methods: Normalisation Process Theory (NPT) informed an on-line survey of health professionals’ views of enablers
and barriers to implementation of Individually Tailored Prescribing (ITP) of medicines. Links to the survey were sent out
through known professional networks using a convenience/snowball sampling approach. Survey questions sought to
identify perceptions of supports/barriers for ITP within the four domains of work described by NPT: sense making,
engagement, action and monitoring. Analysis followed the framework approach developed in our previous work.
Results: Four hundred and nineteen responses were included in the final analysis (67.3% female, 32.7% male; 52.7%
nurse prescribers, 19.8% pharmacists and 21.8% GPs). Almost half (44.9%) were experienced practitioners (16+ years in
practice); around one third reported already routinely offering ITP to their patients. GPs were the group least likely to
recognise this as consistent usual practice. Findings revealed general support for the principles of ITP but significant
variation and inconsistency in understanding and implementation in practice. Our findings reveal four key implications
for practice: the need to raise understanding of ITP as a legitimate part of professional practice; to prioritise the work of
ITP within the range of individual professional activity; to improve the consistency of training and support for
interpretive practice; and to review the impact of formal and informal monitoring processes on practice.
Conclusion: The findings will inform the ongoing development of our new complex intervention (PRIME Prescribing)
to support the individual tailoring of medicines needed to address problematic polypharmacy.
Keywords: Polypharmacy, Medicines optimisation, Individually tailored care
Background
Polypharmacy–the use of multiple medicines in one indi-
vidual on a long-term basis–is now routine in clinical
practice [1]. To optimise the potential benefit of polyphar-
macy on patient-centred outcomes, we must find ways to
support compromise between the views of clinicians and
patients when making decisions about medicines use [1, 2].
Growing numbers of patients take multiple medicines in
order to optimise management of their (often multiple)
disease(s). Polypharmacy can improve patient outcomes
[1, 3, 4]. However, long term medication use can also be
problematic for patients – burdensome in multiple ways
[2, 5–14]. Professional responses have seen the introduc-
tion of medicines optimisation strategies, aiming to make
it easier for patients to take their medicines as prescribed.
But non-concordance is common. For some patients, this
is a passive process – the result of being overwhelmed by
medication demands that they cannot meet. Others
engage in an active resistance to medication use based on
thoughtful evaluation of the pros and cons of medicines
use [12]. Some people are able to negotiate these decisions
with their health care practitioners to reflect the needs
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demands and priorities of their individual circumstances
[2, 6]; but this is by no means universal. Capacity to
support individually tailored prescribing – what Denford
has described as Mutually Agreed Tailoring (MAT) of
medicines [2] - is essential to optimising the use of the
medical intervention that is polypharmacy [1, 2].
Previous research has highlighted barriers to indivi-
dualised (whole person) tailoring of general medical
decisions within current managed health systems [15,
16]. These include a lack of resources, skills and
training supporting delivery of personalised (general-
ist) decision making. Professionals describe wanting to
deliver individually tailored care, but being unable to
do so in practice.
Our team are developing a new model of practice
(PRIME prescribing) to support the MAT of medicines
use highlighted by Denford’s work [2]. To refine our
description of the core elements of our new complex
intervention, we wanted to look specifically at current
professional perceptions of delivering individually tai-
lored prescribing. Our research question asked: what
factors enable or limit health professionals in delivering
individually tailored prescribed in every day practice?
The results will be used to refine our PRIME prescribing
model going in to feasibility testing.
Method
Research design
A cross-sectional mixed methods study using an on-line
survey instrument informed by Normalisation Process
Theory (NPT) [17]. The tool aimed to identify percep-
tions of enablers and barriers to the integration of indi-
vidually tailored prescribing into routine medical
practice in a convenience sample of health professionals.
Sample
We sought to contact health professionals (doctors,
nurses, pharmacists) potentially dealing with problem-
atic polypharmacy including those actively engaged in
prescribing medicines, and those supporting patients
who are taking multiple medicines. We used a snowball
sampling approach to send invitations through known
networks of professional contacts including newsletters
to GPs, pharmacists and other primary health care pro-
fessionals. Networks used included the Society for Aca-
demic Primary Care (SAPC), regional networks for the
Royal College of GPs (RCGP), RCGP First Five network
(recently qualified GPs), known Continuing Professional
Development networks, the Prescribing and Research in
Medicines Management group, the Royal Pharmaceut-
ical Society, and Local Pharmacy Forums. The survey
was publicised in the Pharmacy Research UK Newsletter.
We also sent Twitter invitations targeting RCGP, SAPC,
and known experts in the field; all links included an
invitation to pass details on to individuals’ own net-
works. Our aim was for maximum reach sampling rather
than a statistically representative sample. To support in-
ternal consistency, we opted to use data only from UK
professionals from the 3 main professional groups–doc-
tors, nurse prescribers and pharmacists.
Instrument development
Was informed by Normalisation Process Theory (NPT) -
see Table 1 - with the tool being adapted by the research
team from the NOMAD instrument [18], NPT toolkit
[17], and a previous survey instrument used to examine
barriers to generalist practice [15]. Questions examined
whether participants recognised work within each of the
four key domains described by NPT as needing to hap-
pen for the practice of individually tailored prescribing
to become integrated into every day care. All responses
were anonymous, however basic characteristics on type
and location of professional practice together with years
in practice were collected. The draft survey was road
tested with a small sample of GPs and pharmacists to
ensure it was useable. The full tool is shown in Add-
itional file 1 and can be viewed at this link https://
www.surveymonkey.co.uk/r/7MDY8MF
Data collection: the survey tool (including an invitation,
participant information sheet, consent recording and data
collection) was loaded on to Survey Monkey. The survey
was open for one month (January–February 2016). No
personal identifiable information was collected.
Analysis
For each theme, our analysis sought to identify evidence
of successful work supporting individual tailoring to-
gether with problem areas. For the quantitative data,
Table 1 Using normalisation process theory to assess individually
tailored prescribing
Normalisation Process Theory predicts that for a new intervention to
become integrated into usual practice, there needs to be continuous
investment by all parties in four areas of work. These include
• Making Sense of the intervention: everyone must understand how the
intervention is distinct from other ways of working and why it matters
• Engagement: individuals and collectively people must commit to do
the work of the new practice
• Action: people must have the skills and resources to deliver the new
way of working
• Monitoring: people must get feedback which reinforces and
encourages this way of working
May and colleagues designed a 16 item questionnaire to support the
critical examination of these areas of work in assessing implementation
and integration of ways of working [17]. The tool has been updated into
a more user friendly format in the NOMAD tool [18].
We have previously used the toolkit to examine the enablers and
barriers to delivery of expert generalist practice (EGP) in the primary
care setting [15]. In this study, we will use the same approach to
examine individually tailored prescribing.
Reeve et al. BMC Family Practice  (2018) 19:17 Page 2 of 13
descriptive statistical analysis (absolute numbers, per-
centages and crosstabs reports) was undertaken by JR
with support from SPSS software to describe the charac-
teristics of participants and to compare responses be-
tween professional groups and years of practice. Free
text responses were analysed by JR and JF using a con-
stant comparative approach [15] to identify enablers and
barriers to work in each area. An a priori coding frame-
work was used based on the NPT descriptors (see Table
1) but with researchers remaining alert for new themes
emerging. Disagreement was addressed through discus-
sion. Using a framework analysis approach used in our
previous work in this area [15], findings were critically
reviewed to distil key enablers and barriers to generalist
practice in each of the four domains described by NPT
[17]. We thus sought to describe key changes needed to
support implementation of ITP in everyday practice.
Results
Describing our sample
Four hundred and forty-four professionals responded to
the survey. To enhance the potential generalisability of
our findings, we opted to exclude the small number of
responses received from practitioners outside of the UK
(n = 6), and those from outside the three main profes-
sional groups involved in prescribing within UK primary
care practice - nurse prescribers, pharmacists or GPs (n
= 25). Our final sample thus consisted of 419 people:
52.7% of whom were nurse prescribers, 19.8% pharma-
cists and 21.8% GPs (Table 2). There were more women
than men in our sample – partly reflecting the strong
nursing representation, as well as known gender bias in
survey response [54]. We had responses from people at
all career stages - early (17.7%), middle (37.2%) and later
career (44.9%) – with respondents tending to be more
experienced practitioners. Almost one third of our sam-
ple felt they were already routinely offering ITP to their
patients. GPs were the group least likely to recognise
this as consistent usual practice. However, a further
53.2% of participants described offering ITP some of the
time – including 80.4% of GP respondents.
Analysis of responses from this group are presented
under the four NPT domains used in our survey design.
Sense making
NPT predicts that for ITP to become an integral part of
everyday practice, it must be easy to describe, offer a dis-
tinct model of care that is different from other ways of
working, with all stakeholders being clear about the aims
of practice, expected tasks and value/importance of the
work [17]. Analysis of quantitative and free text re-
sponses revealed four themes in this domain: that ITP is
Table 2 Summarising the professional experience and location of participants
Nurse prescriber GP Pharmacists Total
Total number (% of sample) n = 234 (52.7%) n = 97 (21.8%) n = 88 (19.8%) 419 (100%)
Gender
Male (n, %) 31 (13.2%) 49 (50.5%) 54 (61.3%) 134 (32.0%)
Female (n, %) 200 (85.5%) 48 (29.5%) 34 (38.7%) 282 (67.3%)
Missing data 3 (1.3%) 0 0 3 (0.7%)
Career stage
Early career: ≤5 years (n, %) 58 (24.8%) 5 (5.1%) 11 (12.5%) 74 (17.7%)
Mid career: 6–15 years (n, %) 76 (32.4%) 27 (27.8%) 53 (60.2%) 156 (37.2%)
Later career: 16+ years (n, %) 99 (42.3%) 65 (67%) 24 (27.2%) 188 (44.9%)
Missing data 1 (0.4%) 0 0 1 (0.2%)
Location of practice
England (n, %) 400 (95.5%)
Scotland (n, %) 6 (1.4%)
Ireland (n, %) 4 (0.9%)
Wales (n, %) 9 (2.1%)
Missing data 0
Reporting currently providing ITP
Yes, always (n, %) 96 (41.0%) 13 (13.4%) 12 (13.6%) 121 (28.9%)
Yes, sometimes (n, %) 96 (41.0%) 42 (43.3%) 78 (88.6%) 216 (51.6%)
No (n, %) 28 (12.0%) 17 (17.5%) 5 (5.7%) 50 (11.9%)
Missing data (n, %) 14 (6.0%) 16 (16.5%) 2 (2.3%) 32 (14.6%)
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valued by health care professionals; ITP is valuable; ITP
lacks clarity; and the value of ITP is not shared/recog-
nised more widely.
Although only a third of our respondents identified
themselves as currently offering ITP, 73.4% of respon-
dents reported wanting to do more (67.1% of nurse re-
spondents, 73.9% of pharmacists and 89.7% of GPs.
Most participants felt ITP was a legitimate part of their
professional role (68.9% of all respondents; 93.8% of
GPs, 69.3% of pharmacists and 60.2% of nurse pre-
scribers). ITP is seen as an integral part of wider profes-
sional practice with 356 (85.0%) participants reporting
that their colleagues were doing ITP all or some of the
time. These data indicating the valued and valuable na-
ture of ITP were supported by the free text responses
(Table 3, with further detail given in Table 4).
However, some uncertainties were expressed by pro-
fessionals about the value and purpose of ITP. For ex-
ample, one GP valued individual tailoring “so long as the
patient doesn’t miss out”. Inconsistencies in responses
suggested that some had understood our description of
ITP in a different sense than we had intended. We
understand ITP to support the potential need for com-
promise between the preferences and priorities of guide-
line ‘best practice’ and patient perspectives. Yet we
identified examples of practitioners describing that they
always work within guidelines, whilst also reporting that
they were delivering Individually Tailored Care. Findings
also suggested a possible gap between what professionals
value/want to do, and how they actually practice. A view
echoed in this response from a GP who described:
“I suspect I tailor medicines much less than I would
like to think I do” (GP)
Professionals commonly reported that they thought
their organisation didn’t recognise ITP as a legitimate
role for them, although GPs were more likely to feel this
role was accepted (33.1% of Nurse Prescribers and phar-
macists compared with 52.6% of GPs stated that ITP
was seen as a legitimate role by their employers). Given
the high percentage of participants reporting doing ITC
Table 3 Summarising themes from qualitative analysis
Sense making Theme Description
ITP valued by health care professionals Meeting needs of the individual part of professional identity
ITP valuable to NHS Professionals recognised the value of ITP to the NHS
Clarity on ITP Prioritising the patient/person as the essence of ITP
Value of ITP not shared Organisation values and processes don’t support ITP; some
patients don’t understand value of ITP
Engagement Theme Description
Leadership (individual and collective) Key individual leaders, and collective engagement with ITP
Levels of engagement Variable levels of engagement, with desire for more
Patient engagement Mobilisation of patient engagement through the media
Barriers to engagement Included workload, fragmentation of services, fear, patient
resistance
Action Theme Description
Formal training In generalist practice; within specialist
Experiential learning – phronesis Learning from experience, including working with patients
and colleagues
Collective action Value of peer discussion
Other supports for action Including the media
Partial action Easier to tailor stopping medicines than starting them
Barriers Governance (fear), time, ‘head space’ and practical support
Monitoring Theme Description
Mixed feedback Both supportive and negative feedback on ITP
Challenge of feeding back Hard to quantify benefit
Challenging the status quo Hard to ‘go against’ the guideline
Potential power of feedback Should be a Key Performance Indicator
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Table 4 Detailed account of themes from qualitative analysis. Provides a more detailed description of the qualitative data as
summarised in Table 3
Sense making Theme Subtheme Descriptions from participants
ITP valued by health care professional Defines professional role “our job starts where the guideline ends” (GP)
And not just in managing medicines
(Nurse Prescriber)
ITP valuable to NHS False economy not to “could improve care and save money” (GP)
“Needs to be developed” (Pharmacist)
But uncertain “so long as patient don’t miss out” (GP)
Clarity on ITP Prioritising the patient “advising on the suitability for the patient”
(Pharmacist)
Principle of personalised medicine
Value of ITP not shared By patients “pts… need to understand prescribing as important
as prescribing” (Pharmacist)
By organisational values “recognition from the powers that be that this is
a good thing to do” (GP)
By organisational structures “would be difficult to instigate in practice due to
protocol driven practice” (Nurse Prescriber)
“needs recognition that this is clever subtle
stuff that needs skilled practitioners…not readily
done by rote” (GP)
Engagement Theme Subtheme Descriptions
Leadership Individuals Key leaders, influential colleagues, trained colleagues
support engagement. “working through examples
with trusted colleagues” (pharmacist)
“I remember a Protected Learning Time session
where a geriatrician talked about the rationale for
stopping nearly all the medication” (GP)
Independent contractual status for GPs supports
engagement
Collective action Multidisciplinary team working enhances
engagement with ITP
Levels of engagement Variable Engage with idea if not the practice (GP)
Pharmacists role to recognise the potential need
even if don’t do ourselves
Desire for more “want to do more discontinuation of meds”
(Nurse Prescriber)
Patient engagement Media Media input in to dangers and harms of medicines
can help as it starts a conversation
Barriers to engagements Excess workload “limited by time, caseload and so lack of mental
capacity” (GP).
Time and complexity mitigate against depth of
conversation needed. Stopping meds increases
workload – follow up consults
Fragmentation of care; lack of integration
of vision and process
Inefficiency crowding out effort; disparity between
primary and secondary perspectives, power and
resources; population over individual focus
Fear Limits engagement “it’s a fear of making a mistake
and the potential consequences” (GP)
Patient resistance Patients can be reluctant to change “can be difficult
to persuade carers and patients to change meds
they’ve been taking for a long time and were told
were for life” (Pharmacist)
Patient expectations and lack of understanding of
greyness of medicines
Action Theme Subthemes Descriptions
Formal training GP training Generalist training; basic principles; knowing the
guidelines before you deviate off
“this wasn’t taught when I was training” (GP)
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Table 4 Detailed account of themes from qualitative analysis. Provides a more detailed description of the qualitative data as
summarised in Table 3 (Continued)
Specialist training Prescribing (stop-start); working within specialist
area easier to do ITC
Experiential learning–phronesis Self taught/experience “experience gained intuition”; (GP) practiced at
doing this over a long time
Learn from patients “just day-to-day learning from patients” (GP)
Learn from colleagues Trusted colleagues and influential figures; shared
reflection including on line discussion
Collective action Peer discussion MDT and collaborative action supports ITP
(but can inhibit decision making too as need
full agreement). Supervision
Other support Media To start the conversation
Partial action Easier when stopping meds than starting
Barriers Organisational practice – pay for performance Lack of joined up thinking and communication;
monitoring as a barrier
Time
Resource Qualified and experience staff lacking; resource
prioritises opposite approach; imbalance need
and supply; peer senior support and continuity
of same needed; legal support
“resource restriction means prioritise safety and
supply” (Pharmacist)
Mental capacity and complexity “Limited by time caseload and so lack of mental
capacity” (GP); exhaustion
“To operate outside ‘recognised prescribing’
requires understanding of the clinical evidence
supporting the current guidelines, when there
are gaps in that evidence and when it is therefore
appropriate to choose a different path. An
important variable is the patient wishes and how
these should be accommodated” (Pharmacist)
Practical advice Practical advice, a framework, training
Fear Making and recording defendable decisions; being
castigated by others – clinicians, legally, morally;
uncertainty re risk
“Shared balanced discussions with patients rarely
results in a DEFENDABLE decision. If you are way
of the mark with clinical decisions then it is
probably sensible to share your decision with
colleagues” (GP)
“Fear of being misunderstood & misinterpreted as
undertreatment, apathy, fear of going against
guidelines & being medicolegally vulnerable” (GP)
Monitoring Theme Subtheme Discussion
Mixed feedback Positive From patients and colleagues helps confidence,
helps staff to prescribe less not more – more
PCC “each time I see a positive effect am
motivated to do more” (Nurse Prescriber)
Negative From colleagues (secondary care) and patients
(complaints)
“I stopped metformin in a 90-year-old with dementia,
daughter complained, made me wary to deprescribe”
(GP)
Challenge of feeding back Demonstrating impact Hard to quantify benefits (GP)
Challenging the status quo Fear of feedback “If there is a problem may be hard if against the
guideline” (GP)
Monitoring as a barrier Accept only small deviation, monitoring from
population not individual perspective, pressure
to prescribe to QOF.
“should be a KPI” [KPI = Key Performance indicator]
Potential power of feedback Should be a KPI
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at least some of the time, these data suggest that ITP
is an aspect of practice that may be happening ‘under
the radar’. Free text comments echoed these
responses with reported lack of support from both
non-front line staff, the organisational systems
(including quality structures and pay for performance)
designed to drive care, and patients.
“[ITC needs] recognition from the powers that be that
this is a good thing” (GP)
“patients need to understand not prescribing as
important as prescribing” (Pharmacist)
In summary, survey findings revealed that, in principle,
ITP is recognised as an integral (valued and valuable)
part of professional practice but its lacks a clear and
consistent account of what it is and why it matters. Fur-
thermore, its value is not perceived to be recognised by
the wider healthcare community.
Engagement
NPT states that for ITP to be integrated into usual care,
key individuals must lead the work whilst others must
be willing to both get involved and then stay involved in
this form of work – including operationalising the tasks
in the context of frontline care [17].
As previously stated, some people described them-
selves as doing ITP; more wished to be more involved.
Free text responses offer insights into perceived enablers
and barriers to engagement, with four themes identified
(Tables 3 and 4): leadership, levels of engagement, pa-
tient engagement and barriers to engagement.
Leadership for this work comes from individuals, but
is also supported by collective action in the form of
multidisciplinary team working (Table 4). Different levels
of engagement were evident. Some professionals sup-
ported the idea in principle but did not see it as part of
their own role to deliver this form of care. Others
wanted to engage more with at least some aspects of
practice, for example the discontinuation of medicines
in vulnerable people. Patient support for this form of
practice was acknowledged as an important enabler for
professional engagement. Factors external to the health
service, including the media, were recognised as key to
mobilising patient support.
“it can be difficult to persuade patients and carers to
change medicines they’ve been using for a long time”
(Pharmacist)
Key emerging barriers to engagement related to the
practical constraints of workload placing limits on the
necessary time and ‘head space’ needed to engage with
this complex form of clinical practice.
“limited by time, caseload and so lack of mental
capacity” (GP)
“I barely get through the day reacting” (GP)
The survey findings again indicate a variable response
in this second domain of work described by NPT. Re-
sults highlighted professionals both leading and engaging
with work to deliver ITP, but also demonstrated signifi-
cant barriers to engagement, notably in prioritising this
work within a busy wider schedule of service delivery.
The importance of engaging patients, as a key resource
to support this activity, was highlighted.
Action
The third domain of work described by NPT focuses on
action – that the people tasked with delivering ITP are
able to do the tasks required of them. This includes the
need for specific activities of work to be allocated to
those with the right skills to do them, the provision of
necessary resources by the host organisation, and that
people then do the work [17]. Again, the data reveal a
varied picture within five key themes: formal training,
experiential learning, collective action, partial action and
barriers to action (Tables 3 and 4).
Respondents were asked to indicate if they had ever
had formal or informal training in the skills needed to
tailor prescribing to individual needs. Table 5 summa-
rises the results which showed low levels of formal train-
ing in this form of practice with high proportions of
respondents across all professional groups expressing a
desire for more training.
However, people described having informally acquired
skills, described as “experience gained intuition” gath-
ered through “practice…over a long time” (Table 4).
Practitioners identified both patients and colleagues as
important sources of support for this form of practice –
more so than formal training or professional status
(Table 5). Free text responses revealed the significance of
collective action (multidisciplinary working and discus-
sions) in supporting this complex form of practice
(Tables 3 and 4). The importance of peer discussion to
support this form of practice was highlighted. This was
accessed through a number of routes, including
multidisciplinary team meetings, learning from trusted
colleagues and influential figures, and the value of peer
discussion including on-line discussion groups.
We observed professional differences within reported
levels of confidence in different aspects of the role of
ITP (Table 5), reflecting the level of prescribing-related
training and experience within each group. Pharmacists
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and GPs were generally (although not consistently) more
confident in deciding on medicines to change. Nurses and
GPs were more comfortable with monitoring the impact of
changes – perhaps reflecting their continuing clinical con-
tact with the patients. Overall, there was greater expressed
confidence in aspects of prescribing practice that also form
part of the usual practice of medicines management –
namely assessing patients’ own management of their medi-
cines. A relatively low proportion of respondents expressed
confidence in eliciting patient goals for their medication, a
finding supported by the existing literature.
Consistent with this mixed picture with reference to
training and experience, participants also described ‘par-
tial action’ – an incomplete tailoring of prescribing. For
example, they described finding it easier to stop medi-
cines than to think differently about starting them. They
called for more practical resources to help them
translate an ideal of practice into reality on the ground
(training, a framework of practice, practical advice).
“This was not taught when I trained. A guide to
implement this safely would be helpful” (GP)
Drawing on past research, we asked participants to de-
scribe whether they had experienced previously described
[15] barriers to individual tailoring of care. Professionals
report high levels of these known barriers (Table 6). Over
half reported time as a significant barrier, 43.9% reported
competing pressures and 40.5% reported making/record-
ing a defendable decision as a key barrier to ITP. Interest-
ingly about half of GPs compared with one third of nurse
prescribers described this latter barrier. Potentially linked
with this was concern about a lack of resources to support
estimation of risk – see Table 4).
Organisational structures including performance mon-
itoring were also consistently highlighted as a barrier to
this way of working. Respondents described that they
lacked the necessary resources from their host organisa-
tion to support this work, although with interprofes-
sional differences in perceptions. Only 118 (50.4%) of
nurse prescribers and 45 (51.1%) of pharmacists de-
scribed having sufficient resources, whilst 72 (74.2%) of
GPs identified that that they did have sufficient resource.
It is unclear whether this represents a true difference in
the support offered to professional groups or an artefact
of the research process with variable understanding of
what the survey instrument meant by ‘resource’.
Perhaps the most stark identified barrier was the
theme of ‘fear’ – of being castigated by other profes-
sionals for not following guidelines, of the medicolegal
implications of this way of working, and a lack of confi-
dence in making and recording “defendable decisions”.
Table 6 Number (%) of respondents reporting previously identified barriers to ITP
Barriers: Time Competing pressures Risk stratification Defend decision Lack risk estimation support
Nurse prescriber (n = 234) 91 (38.9) 76 (32.5) 42 (17.9) 87 (37.1) 83 (35.5)
Pharmacist (n = 88) 48 (54.5) 45 (51.1) 31 (35.2) 38 (43.2) 39 (44.3)
GP (n = 97) 87 (89.7) 65 (67) 45 (46.4) 49 (50.5) 68 (70.1)
All (n = 419) 235 (56.1) 195 (46.5) 120 (28.6) 180 (43.0) 200 (47.7)
Table 5 Reported skills, training and support for ITP across professional groups
Nurse prescribers (n = 234) Pharmacists (n = 88) GP (n = 97) Total (n = 419)
Numbers (%) reporting medium or high levels of practice skills in…
Assessing patient management of medicines 153 (65.4) 66 (75) 75 (77.3) 309 (73.7)
Eliciting patient goals 119 (50.1) 48 (54.5) 57 (58.8) 237 (56.6)
Deciding medicines meds to change 111 (47.4) 55 (62.5) 72 (74.2) 250 (59.7)
Monitoring impact of change 122 (52.1) 39 (44.3) 50 (51.5) 226 (53.9)
Described support from [n(%)]
My training 114 (48.7) 47 (53.4) 43 (44.3) 219 (52.3)
My professional status 80 (34.2) 38 (43.2) 48 (49.5) 176 (42.0)
My colleagues 131 (60.0) 57 (64.8) 61 (62.9) 264 (63.0)
My patients 130 (55.6) 53 (60.2) 73 (75.3) 272 (65.0)
Expressed training experience/needs [n(%)]
Had formal training 39 (16.7) 16 (18.2) 12 (12.4) 74 (17.7)
Had informal training 81 (34.6) 37 (42.0) 51 (52.6) 178 (42.5)
Would like more training 129 (55.1) 59 (67.0) 67 (69.1) 267 (63.7)
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“a fear of making a mistake and the potential
consequences”(Nurse Prescriber)
“hard to record decision and be sure will be
understood” (GP)
There was a call for additional qualified and experienced
staff to support colleagues in this form of practice. The
need for continuity of senior support, in terms of both
clinical mentorship and medicolegal advice, was
highlighted.
In summary, responses in the Action domain revealed
the practical challenges in delivering a model of care that
many supported in principle. Much of the existing training
for this role was identified as experiential, including recog-
nising the importance of peer support from colleagues.
There was suggestion from some, but not all, that formal
GP training may support this way of working. The recur-
ring theme of lack of time and energy once more appeared
strongly – of exhausted staff being unable to perform this
highest-level clinical function. The other key identified
barrier was fear – of not being supported in this form of
decision making by other health professionals, by the ‘sys-
tem’ and perhaps by patients too. This is an issue that
feeds in to our final NPT domain.
Monitoring
NTP states that for ITP to be integrated into usual prac-
tice, stakeholders must get feedback about the effect of
the intervention; individuals and the collective must as-
sess the feedback as being supportive of the tasks of ITP;
and feedback must support ongoing learning and devel-
opment [17]. Analysis in this domain again revealed sig-
nificant concerns/barriers to integration.
In an era of evidence-based, or evidence-informed,
medicine, we asked our participants if they were aware
of any evidence supporting ITP. Fifty-five respondents
(13.1%) said yes; 290 (69.2%) said no.
Only one in four (26.3%) participants described having
received feedback on their ITP, and of these, 37.2% de-
scribing that feedback had changed their practice. There
was no difference identified between professional groups.
Free text responses revealed four themes (Tables 3 and
4): mixed feedback, challenges of feeding back, challen-
ging the status quo, and potential power of feedback.
Feedback had a mixed effect on practice. Positive
feedback helped build confidence, encouraging staff to
“prescribe less not more” and in a more “patient-
centred” approach. One Nurse Prescriber described
“each time I see a positive effect, I am motivated to
do more”. However, others spoke of how complaints
from both colleagues (in secondary care) and carers
made them warier:
“I stopped metformin in a 90-year-old with dementia,
daughter complained, made me wary to deprescribe” (GP)
Others also reported current feedback mechanisms (per-
formance monitoring) as a significant barrier – the
“pressure to prescribe to QOF” (GP) with only “small
deviations” permitted.
Participants reflected on the challenges of demonstrating
the impact of individually tailored care beyond the effect on
an individual patient – in recognising potential benefits.
“will be difficult to quantify downstream costs [that]
will be saved - mainly by those outside of my practice
so i will do work and savings will be made elsewhere”
(GP)
But recognised the potential power of feedback as a
source of support for practice commenting that indi-
vidually tailored prescribing should be a “key perform-
ance indicator” (GP).
In summary, responses revealed that current feed-
back–whether formal or informal – is largely non-
supportive or even unsupportive of ITC. Performance
monitoring therefore functions as a further barrier to
changing to an individually tailored model of prescrib-
ing. Respondents revealed that positive/reinforcing
feedback comes mainly from patients as well as discus-
sion with colleagues – through informal sources.
Discussion
Summary
Our findings revealed general support for a principle of
ITP but significant variation and inconsistency in under-
standing and implementation of practice. Key themes
emerging from our analysis describe 3 enablers and 4
barriers for ITP (Table 7). ITP is recognised as an inte-
gral part of professional practice but with a lack of clar-
ity in describing what it is which limits wider
engagement and understanding. ITP is not prioritised
within current models and organisation of care. Delivery
of ITP is supported by experiential and peer learning but
professionals identify a need for more help in developing
the practical skills to support Defendable Decision Mak-
ing. Professionals highlight the importance of being able
to follow up patients in order to monitor the impact of
decision making, but also the need to review the impact
of formal performance monitoring as a barrier to ITP.
From these findings, we describe four key implications
for practice: the need to raise understanding of ITP as a
legitimate part of professional practice; to prioritise the
work of ITP within the range of individual professional
activity; to improve the consistency of training and sup-
port for interpretive practice; and to review the impact
of formal and informal monitoring processes on practice.
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Comparison with existing literature
The identified barriers resonate with, and extend, the find-
ings of our previous survey on barriers to generalist practice
[15]. The current survey recognises that clarity of under-
standing, prioritisation of work, training and feedback re-
main issues that need to be addressed in the new model of
care. However, the survey adds to previous findings by
highlighting the importance of patient understanding of the
model of care as a potential enabler and barrier. Patient
support was identified as a key driver for ITP by respon-
dents; fear of patient dissent or complaint as a barrier. This
survey extends the previous findings in noting the potential
for multiprofessional groups in supporting engagement
with, and so delivery of this model of practice. Although all
professional groups recognised the need for more training,
pharmacists in particular were identified as an underdevel-
oped resource. The importance of medicolegal training and
support was a strong theme, and resonates with informal
discussions on this topic that we have held with profes-
sional stakeholder groups. The revised PRIME Prescribing
model will recognise the need for medicolegal training in
its training programme. Finally, the results highlight the im-
portance of shared reflection and monitoring and of peer
professional support, an extension of our previous survey
[15]. This observation also resonates with the wider litera-
ture on professional practice. Gabbay and Le May describe
the importance of peer reflection in supporting complex,
beyond guideline practice [19].
Our survey also resonates and extends observations
from previous qualitative work. Both Denford and col-
leagues [2] and Sinnott [20] highlight professional vari-
ation in understanding of the process of ITP but also
recognise the significance of a process of compromise.
Our survey extends those observations to a larger sam-
ple, and across professional boundaries. Barriers of time
and resource to engagement with ITP have been previ-
ously described [586 but our findings go further in
emphasising the importance of ‘head space’. The need is
not simply for more time, but for protected time that
recognises the significant intellectual challenges of this
work. Practitioners may not just need more time, but
fewer other demands/activities to leave them with suffi-
cient mental capacity for the work involved.
The RCGP recognises GPs as expert generalists [21].
Our survey findings suggest that many are working in
that role – able to individually tailor care to the needs of
a whole person, the individual. However, participants
also report a significant gap in their training – a lack of
formal training to deliver these tasks. Indeed, many re-
port training being acquired through experience and
learning from significant others. This requires us to have
a workforce able to act in that mentor role, and with
people working in roles and rotas that allow them access
to that apprenticeship. The findings highlight a need to
look again at the RCGP training curriculum to both
strengthen formal training and protect the informal.
Concerns about the impact of current performance
monitoring on individually tailored practice have been
previously recognised [20]. Our survey offers new data in
highlighting professional suggestions that monitoring could
be explicitly used to encourage this model of care [21].
Strengths and limitations of our work
Our work describes theory informed research, under-
pinned by the principles described in the MRC Complex
Interventions Framework [22] to develop a new complex
intervention. Support for our emerging model comes
from the observation that our findings resonate with
previous research and with the experiences of clinical
audiences we have shared the findings with. This report
offers a transparent description of development of an
intervention supported by literature and empirical
findings.
However, we recognise a number of ongoing limita-
tions with the work. This survey focused only on profes-
sional perceptions. We have public and patient partners
actively working with us on the development of all
stages of this work [23], and we have actively prioritised
literature on patient experiences of medicines use in de-
signing our work [24]. However, we still need to more
formally examine the views of patients who have been
unconnected with the work to date.
The mixed responses reveal some lack of clarity/un-
derstanding of what we meant by ITP in our survey
which requires us to exercise caution in interpreting and
extrapolating our findings. We deliberately chose not to
fully describe the proposed PRIME Prescribing model in
our survey so as to allow people to comment on their
own current practice. But our work may now benefit
from repeating the study with a clearer description of
the specific intervention that we are proposing in the
participant information.
Our snowball sample was never intended to be fully
representative. Our research methodology is based on a
translational approach – action research involving clini-
cians and academics working together to develop imple-
ment and evaluate new models of working [25]. As such
the current model is evidence and stakeholder informed,
but subject to ongoing review through implementation
and formative evaluation.
Implications for research and practice
The findings from this study are being used to refine the
description of our PRIME Prescribing intervention. Key
additions include the inclusion of a section on medicole-
gal issues and patient safety within the educational com-
ponent supporting interpretive practice [26] and clinical
decision making. We will work with our patient partners
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to describe practical support for clinicians in engaging
their patients in a change to ITP, and facilitate proactive
peer reflection and support to enhance the critical pro-
fessional learning needed to support ‘beyond protocol’
care [19]. We will actively work with stakeholders to
consider how we might include a key performance indi-
cator based on fidelity of delivery of a process of indi-
vidually tailored care. Finally, we will be actively working
to raise the profile and understanding of ITP amongst
patient and non-clinical groups (for example, service
managers).
Conclusion
The 2013 Kings Fund report argued that to optimise the
potential benefit of polypharmacy on patient-centred out-
comes, we must find ways to support compromise be-
tween the views of clinicians and patients when making
decisions about medicines use [1]. Our survey findings
highlight that such work is already happening, but incon-
sistently and with insufficient support. We have described
professional perceptions of changes needed to enhance
the individually tailored use of medicines. We now
propose to test the findings of this study through incorp-
orating them into the refined description of the complex
intervention that is PRIME Prescribing, and so evaluate
the impact of introducing these changes to practice.
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